VEDP's Supply Chain Optimization Program Receives NASBITE International Program Excellence Award

Eric Arocho is associate vice president at Eli Lilly and Company and the site lead on the company’s facility in Goochland County, Virginia - announced last year. The Goochland facility, expected to be completed within the next five years, will produce both critical drug components and finished medicines to support Lilly’s emerging bioconjugate platform and monoclonal antibody portfolio.

The pharmaceutical manufacturing innovation that came out of a Virginia university is changing the way medicines are made. The Commonwealth’s universities and the rest of its biopharma research community are making sure Virginia is ready to make the medicines of the future.

VEDP's Vice President of Manufacturing Sneha Atwal speaks with Dave Maraldo, senior vice president of Human Health Manufacturing Operations at Merck, one of the five largest biopharmaceutical companies in the world.

Investments from Virginia Tech, Carilion support critical studies in brain, heart, and cancer issues.

A look at the partnerships and targeted investment that created the next U.S. biopharma hotspot — and the work that still needs to be done.

Pam Cheng is executive vice president of global operations and IT and chief sustainability officer at AstraZeneca, which recently announced a new facility in Albemarle County — the company’s first in Virginia. VEDP Vice President of Manufacturing Sneha Atwal spoke with Cheng about the Commonwealth’s rapid rise in pharmaceutical engineering and the company’s plans for the new facility.

Virginia’s pharma manufacturing successes build on years of ecosystem development.

Virginia’s cities, counties, and towns represent a wide range of living situations, with a location to support any lifestyle.